Ian F Pollack Selected Research

lysine diisocyanate-glycerol poly(urea-urethane)

9/2008	Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles.
7/2008	LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian F Pollack Research Topics

Disease

107	Glioma (Gliomas) 08/2022 - 02/2002
94	Neoplasms (Cancer) 01/2022 - 02/2002
40	Brain Neoplasms (Brain Tumor) 08/2022 - 03/2002
20	Medulloblastoma 11/2021 - 12/2007
18	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 09/2002
8	Hydrocephalus (Hydrocephaly) 04/2022 - 09/2004
8	Central Nervous System Neoplasms 01/2022 - 08/2004
8	Craniosynostoses (Craniosynostosis) 06/2021 - 01/2010
8	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 08/2005
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 06/2012
6	Ependymoma 01/2019 - 08/2011
5	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 08/2006
4	Hemorrhage 01/2021 - 09/2004
4	Diffuse Intrinsic Pontine Glioma 05/2019 - 04/2011
4	Hypoxia (Hypoxemia) 06/2016 - 09/2004
4	Carcinogenesis 08/2011 - 08/2003
3	Intracranial Hypertension 02/2016 - 08/2011
3	Melanoma (Melanoma, Malignant) 11/2013 - 08/2004
3	Disease Progression 10/2013 - 07/2008
2	Infections 03/2022 - 01/2021
2	Synostosis 06/2021 - 01/2010
2	Craniopharyngioma (Craniopharyngiomas) 11/2020 - 12/2012
2	Syringomyelia (Morvan's Disease) 10/2019 - 10/2013
2	Arnold-Chiari Malformation (Arnold-Chiari Syndrome) 10/2019 - 10/2013
2	Neurofibromatoses (Neurofibromatosis) 01/2019 - 01/2017
2	Exanthema (Rash) 01/2019 - 08/2017
2	Edema (Dropsy) 12/2017 - 09/2004
2	Headache (Headaches) 08/2017 - 01/2005
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2016 - 05/2002

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 01/2018 - 02/2002
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
13	Biological ProductsIBA 01/2019 - 03/2002
13	VaccinesIBA 02/2017 - 06/2002
11	Peptides (Polypeptides)IBA 02/2017 - 09/2002
9	EpitopesIBA 12/2016 - 09/2002
9	Temozolomide (Temodar)FDA LinkGeneric 10/2016 - 06/2003
8	Carboplatin (JM8)FDA LinkGeneric 09/2021 - 12/2008
8	Pharmaceutical PreparationsIBA 01/2020 - 12/2009
7	EnzymesIBA 01/2022 - 03/2005
7	SurvivinIBA 01/2017 - 07/2008
6	dipinacoline glutamateIBA 05/2022 - 04/2011
6	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2009
6	Histones (Histone)IBA 01/2022 - 12/2005
6	ParaffinIBA 06/2019 - 02/2002
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2002
5	Lysine (L-Lysine)FDA Link 01/2022 - 04/2009
5	ABT-737IBA 01/2015 - 06/2012
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2022 - 09/2004
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2005
4	LigandsIBA 01/2021 - 01/2011
4	InterferonsIBA 11/2020 - 08/2004
4	Bortezomib (Velcade)FDA Link 01/2020 - 01/2011
4	Histone Deacetylase InhibitorsIBA 01/2020 - 12/2005
4	Formaldehyde (Formol)FDA Link 06/2019 - 03/2011
4	gallium arsenide (GaAs)IBA 12/2016 - 07/2008
4	Lomustine (CCNU)FDA Link 10/2016 - 09/2003
4	ErbB Receptors (EGF Receptor)IBA 02/2016 - 09/2005
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 08/2005
4	Bevacizumab (Avastin)FDA Link 01/2015 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2002
4	Alkylating AgentsIBA 12/2012 - 07/2006
4	CytokinesIBA 10/2011 - 10/2004
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2009 - 01/2006
3	AZD 6244IBA 08/2022 - 08/2017
3	Methionine (L-Methionine)FDA Link 07/2022 - 01/2018
3	NucleotidesIBA 11/2021 - 10/2019
3	Isotretinoin (Accutane)FDA LinkGeneric 09/2021 - 06/2003
3	Proteasome InhibitorsIBA 01/2020 - 01/2011
3	Protein Subunit VaccinesIBA 01/2018 - 01/2013
3	Mitogen-Activated Protein KinasesIBA 08/2017 - 12/2006
3	sepantroniumIBA 01/2017 - 03/2013
3	TensinsIBA 02/2016 - 01/2006
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2016 - 01/2006
3	Vincristine (Oncovin)FDA LinkGeneric 01/2016 - 09/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015 - 01/2011
3	CaspasesIBA 01/2015 - 05/2002
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2014 - 01/2006
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 12/2006
3	tipifarnib (R115777)IBA 04/2011 - 12/2007
3	Gefitinib (Iressa)FDA Link 04/2011 - 05/2006
3	tanespimycin (17AAG)IBA 09/2008 - 01/2006
3	Interleukin-4 (Interleukin 4)IBA 12/2007 - 08/2003
2	Aurora KinasesIBA 01/2022 - 01/2015
2	dinaciclibIBA 01/2018 - 02/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2017 - 12/2009
2	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 06/2016 - 05/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2016 - 01/2006

Therapy/Procedure

57	Therapeutics 01/2022 - 03/2002
30	Drug Therapy (Chemotherapy) 01/2021 - 06/2002
27	Radiotherapy 01/2021 - 08/2002
13	Immunotherapy 01/2022 - 08/2003
8	Craniotomy 07/2020 - 07/2002
7	Sutures (Suture) 06/2021 - 01/2010
4	Ventriculostomy 04/2022 - 06/2020
4	Decompression 10/2019 - 04/2007
3	Cautery 04/2022 - 06/2020
3	Ventriculoperitoneal Shunt 11/2021 - 08/2015
3	Craniospinal Irradiation 01/2016 - 01/2010
2	Subcutaneous Injections 01/2017 - 12/2012